Pivotal a rising star
Pivotal has been selected as one of the few firms that attracted recognition from the Pharma IQ network as a “RISING STAR"
We´re delighted to bring to...
News
Sarah Cannon development innovations collaborates with Pivotal on immuno-oncology trials
New collaboration aims to further accelerate the delivery of novel treatments for multiple difficult-to-treat cancers in Europe
Sarah Cannon Development Innovations announced today a new strategic collaboration with Pivotal...
Pivotal has participated in the 36th annual JP Morgan healthcare conference
The annual conference was held in San Francisco (California)
Pivotal, represented by members of our Senior Management, has participated in the 36th Annual JP Morgan HealthCare Conference held in...
Pivotals hit in the European Society for Medical Oncology congress
ESMO took place in Madrid from the 08th until the 12th of September
On Tuesday, September 12th, the European Society for Medical Oncology Congress (ESMO) ended in Madrid as...
Pivotal participates in the 2017 European Society for Medical Oncology (ESMO) congress in Madrid, Spain
Pivotal and ESMO working on different levels to improve prevention, diagnosis, treatment, and palliative care of cancer patients through clinical research
Pivotal, the Madrid-based, European-wide Clinical Research Organization (CRO),...
Pivotal´s success in the European Hematology Association congress (EHA) with a high impact on the media
Important online media coverage
On Sunday, June 25th, the 22nd European Hematology Association Congress (EHA) came to a close. The conference was held at the IFEMA Trade Fair Institution...
Pivotal participates in the European Hematology Association (EHA) congress
The EHA congress will be held for the first time in Madrid
Pivotal, the Madrid-based European-wide Clinical Research Organisation (CRO), is participating with a booth at the forthcoming <a...